ENLV Enlivex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Get AI intraday signals

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENLV
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENLV
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

ENLV is expected to report earnings to rise 62.50% to -19 cents per share on December 02

Enlivex Therapeutics Ltd ENLV Stock Earnings Reports

Q3'24

Est.

$-0.19

Q2'24

Beat

by $0.03

Q1'24

Est.

$-0.25

Q4'23

Missed

by $0.21

Q3'23

Est.

$-0.32

The last earnings report on August 19 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 32.41K shares outstanding, the current market capitalization sits at 35.11M.

A.I. Advisor

published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

14 Einstein Street

Phone

+972 26208072

Employees

Web

https://www.enlivex.com

Interesting Tickers

CRYPTO / NAME	Price $	Chg $	Chg %
		1 Day
BTC.X	62445.090000	2170.586000	+3.60%
Bitcoin cryptocurrency
SPY	579.58	3.45	+0.60%
SPDR® S&P 500® ETF Trust
GME	20.83	-0.08	-0.38%
GameStop Corp
AAPL	227.55	-1.49	-0.65%
Apple
TSLA	217.80	-20.97	-8.78%
Tesla

ENLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

Ticker / NAME	Correlation To ENLV	1D Price Change %
ENLV	100%	-1.99%
APVO - ENLV	36% Loosely correlated	-2.87%
ONCT - ENLV	34% Loosely correlated	-0.88%
FATE - ENLV	32% Poorly correlated	+5.10%
VKTX - ENLV	30% Poorly correlated	+5.43%
SLNO - ENLV	29% Poorly correlated	+7.78%
More